Neutrons Settle Long-Held Debate on Cancer Drug Design

In just two neutron experiments, Oak Ridge National Laboratory scientists discovered remarkable details about the function of an enzyme that can aid drug design for aggressive cancers. Watch this video to learn more.

“With more than 200 types, cancer continues to be a devastating disease,” said ORNL senior scientist Andrey Kovalevsky  . “That means, if we’re ever going to beat the disease, it’s going to require exploring every option and studying every aspect of the disease at every level — from tumors, cells and molecules down to individual atoms.”


Topics:
Medical